SCHEMBL24011

SCHEMBL24011

FC[S]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23777 0.72
SCHEMBL23044067 0.61
SCHEMBL2339 0.61
SCHEMBL127813 0.61
SCHEMBL6113934 0.55
SCHEMBL23961 0.55
Hydrochloric Acid SCHEMBL9799153 0.55
Water SCHEMBL25365379 0.55
SCHEMBL11038950 0.55
SCHEMBL26810 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2965 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024109922-A1 BRIDGED RING PYRIDAZINE COMPOUND AND USE THEREOF 成都赜灵生物医药科技有限公司 2024-05-30 WO claimed
CN-117402091-A Synthetic method of sodium monofluoromethylsulfinate 瑞博(杭州)医药科技有限公司 2024-01-16 CN claimed
CN-112724055-B Method for synthesizing aromatic monofluoromethylthio compounds by one-pot method 南京理工大学 2022-06-07 CN claimed
CN-112724055-A Method for synthesizing aromatic monofluoromethylthio compounds by one-pot method 南京理工大学 2021-04-30 CN claimed
CN-111909144-A Quinazoline DNA-PK inhibitor 山东轩竹医药科技有限公司 2020-11-10 CN claimed
US-10028942-B2 3-substituted pyrazoles and uses thereof GENENTECH, INC. (US) 2018-07-24 US claimed
EP-2945938-B1 3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS HOFFMANN LA ROCHE (CH) 2018-03-07 EP claimed
US-20170087137-A1 3-SUBSTITUTED PYRAZOLES AND USES THEREOF GENENTECH, INC. (US) 2017-03-30 US claimed
US-9550777-B2 3-substituted pyrazoles and use as DLK inhibitors GENENTECH, INC. (US) 2017-01-24 US claimed
WO-2016174049-A1 ANTI-PARASITIC COMBINATIONS INCLUDING HALOGEN-SUBSTITUTED COMPOUNDS BAYER ANIMAL HEALTH GMBH (DE) 2016-11-03 WO claimed
EP-0264021-A2 0-Aryl-N'-(triazin-2-yl)-isourea BAYER AG (DE) 1988-04-20 EP claimed
EP-0246534-A2 Optically pure 4,5-disubstituted gamma-butyrolactame enantiomers, process for their preparation and their use BAYER AG (DE) 1987-11-25 EP claimed
US-4650809-A AGRICULTURE BAYER AKTIENGESELLSCHAFT (DE) 1987-03-17 US claimed
EP-0132680-B1 SUBSTITUTED FURAZANS BAYER AG (DE) 1987-01-28 EP claimed
EP-0118070-B1 SUBSTITUTED 1,3-DIAZOLYL-2-PROPANOLS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTIMYCOTIC COMPOUNDS BAYER AG (DE) 1986-10-08 EP claimed
EP-0070464-B1 SUBSTITUTED PHENYLCYCLOPROPANECARBOXYLIC-ACID ESTERS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES BAYER AG (DE) 1985-10-02 EP claimed
EP-0040573-B1 2-SUBSTITUTED-4-HYDROXY-3-QUINOLINECARBOXYLIC ACIDS, THEIR PREPARATION, THEIR USE AS MEDICAMENTS, COMPOSITIONS CONTAINING THEM AND INTERMEDIATES ROUSSEL-UCLAF (FR) 1984-08-01 EP claimed
EP-0045980-B1 COMPOUNDS USEFUL IN THE PREPARATION OF AMINOPIPERIDINES WITH ANORECTIC PROPERTIES SANOFI S.A. (FR) 1983-10-05 EP claimed
EP-0012639-A2 Quinolein-3-carboxylic acid derivatives, process for their preparation, their use in medicines and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1980-06-25 EP claimed
US-4010179-A ANTIMICROBIAL, ANTINEOPLASTIC AMERICAN CYANAMID COMPANY (US) 1977-03-01 US claimed